Riboway Therapeutics is a Boston-based biotech leveraging AI to decode RNA biology and develop RNA-targeted therapeutics. We aim to revolutionize how targets are drugged and make every protein druggable. Our smart RNA-targeting technology enables precise control of protein expression and function—upregulating, downregulating, activating, or inhibiting proteins as needed.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 700 Main Street, Cambridge,ma 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://riboway.com/
- HQ
- Cambridge, MA
Riboway Therapeutics Questions
Riboway Therapeutics's website is https://riboway.com/
Riboway Therapeutics's LinkedIn profile is https://www.linkedin.com/company/riboway
Riboway Therapeutics has
2 employees.
View email and phone details for 2
employees at Riboway Therapeutics.
Riboway Therapeutics's industry is
Biotechnology Research
Riboway Therapeutics's top competitors are
Genie Techbio Inc.,
Fosun Pharma Usa Inc.,
Reprogram Biosciences,
Kiragen Bio,
Lilium Therapeutics,
Sequestbio,
Matrisome Bio,
General Oncology,
Hydrogene Therapeutics,
Accent Therapeutics, Inc..
Riboway Therapeutics's categories are Biotechnology Research
Riboway Therapeutics's founding year is 2024
